Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis

This study investigated the effects of a skin protectant solution (dimethicone 2%) on clinical signs and skin barrier function in canine atopic dermatitis (AD). Eighteen dogs with AD were randomly divided into two groups, one received dimethicone and the other received the vehicle (cyclomethicone) o...

Full description

Saved in:
Bibliographic Details
Main Authors: C. Pellicoro, R. Marsella, K. Ahrens
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Veterinary Medicine International
Online Access:http://dx.doi.org/10.1155/2013/239186
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166721402372096
author C. Pellicoro
R. Marsella
K. Ahrens
author_facet C. Pellicoro
R. Marsella
K. Ahrens
author_sort C. Pellicoro
collection DOAJ
description This study investigated the effects of a skin protectant solution (dimethicone 2%) on clinical signs and skin barrier function in canine atopic dermatitis (AD). Eighteen dogs with AD were randomly divided into two groups, one received dimethicone and the other received the vehicle (cyclomethicone) on selected areas (pinnae, groin, and axillae) daily for 4 weeks. Owners and investigators were blinded regarding group allocation. Clinical efficacy was evaluated using a scoring system and skin barrier by measuring the transepidermal water loss. Twelve dogs completed the study (50% drop rate in the vehicle and 20% in the dimethicone). For clinical signs, analysis of variance showed an effect of time (; day 0 day 28) and region (axillae groin pinnae) but no effect of group or group × time interaction. For transepidermal water loss, analysis of variance showed only a main effect of region (axillae pinnae groin). Pearson found no correlation between transepidermal water loss and clinical scores. In this pilot study dimethicone had no significant effect on clinical signs and transepidermal water loss in canine atopic dermatitis.
format Article
id doaj-art-de4fe0ec33194970be91f7ab7d4472b3
institution OA Journals
issn 2090-8113
2042-0048
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Veterinary Medicine International
spelling doaj-art-de4fe0ec33194970be91f7ab7d4472b32025-08-20T02:21:21ZengWileyVeterinary Medicine International2090-81132042-00482013-01-01201310.1155/2013/239186239186Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic DermatitisC. Pellicoro0R. Marsella1K. Ahrens2College of Veterinary Medicine, University of Bari, Piazza Umberto I, 1-70121 Bari, ItalyDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610-0126, USADepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610-0126, USAThis study investigated the effects of a skin protectant solution (dimethicone 2%) on clinical signs and skin barrier function in canine atopic dermatitis (AD). Eighteen dogs with AD were randomly divided into two groups, one received dimethicone and the other received the vehicle (cyclomethicone) on selected areas (pinnae, groin, and axillae) daily for 4 weeks. Owners and investigators were blinded regarding group allocation. Clinical efficacy was evaluated using a scoring system and skin barrier by measuring the transepidermal water loss. Twelve dogs completed the study (50% drop rate in the vehicle and 20% in the dimethicone). For clinical signs, analysis of variance showed an effect of time (; day 0 day 28) and region (axillae groin pinnae) but no effect of group or group × time interaction. For transepidermal water loss, analysis of variance showed only a main effect of region (axillae pinnae groin). Pearson found no correlation between transepidermal water loss and clinical scores. In this pilot study dimethicone had no significant effect on clinical signs and transepidermal water loss in canine atopic dermatitis.http://dx.doi.org/10.1155/2013/239186
spellingShingle C. Pellicoro
R. Marsella
K. Ahrens
Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
Veterinary Medicine International
title Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
title_full Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
title_fullStr Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
title_full_unstemmed Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
title_short Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis
title_sort pilot study to evaluate the effect of topical dimethicone on clinical signs and skin barrier function in dogs with naturally occurring atopic dermatitis
url http://dx.doi.org/10.1155/2013/239186
work_keys_str_mv AT cpellicoro pilotstudytoevaluatetheeffectoftopicaldimethiconeonclinicalsignsandskinbarrierfunctionindogswithnaturallyoccurringatopicdermatitis
AT rmarsella pilotstudytoevaluatetheeffectoftopicaldimethiconeonclinicalsignsandskinbarrierfunctionindogswithnaturallyoccurringatopicdermatitis
AT kahrens pilotstudytoevaluatetheeffectoftopicaldimethiconeonclinicalsignsandskinbarrierfunctionindogswithnaturallyoccurringatopicdermatitis